We report the neuropathological findings of a patient who died from complications of COVID-19. The decedent was initially hospitalized for surgical management of underlying coronary artery disease.
R. Reichard+5 more
semanticscholar +1 more source
Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination [PDF]
We present three cases fulfilling diagnostic criteria of hemorrhagic variants of acute disseminated encephalomyelitis (acute hemorrhagic encephalomyelitis, AHEM) occurring within 9 days after the first shot of ChAdOx1 nCoV-19.
Ancau, Mihai+12 more
core +1 more source
Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine
We are facing a global pandemic with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, according to the definition of the World Health Organization (WHO), since 11 March 2020.
Gulay Ozgen Kenangil+3 more
semanticscholar +1 more source
Acuted Disseminated Encephalomyelitis [PDF]
Acute disseminated encephalomyelitis (ADEM) is a disorder of the central nervous system (CNS) characterized by an acute event, typically with encephalopathy, in which diffuse CNS involvement occurs. It may follow an infectious event and occurs more commonly in young children. Pulse steroid treatment is frequently used to treat ADEM.
Joy Parrish, E. Ann Yeh
openaire +3 more sources
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19
Background and Objectives Since the onset of the COVID-19 pandemic, a growing number of reports have described cases of acute disseminated encephalomyelitis (ADEM) and acute hemorrhagic leukoencephalitis (AHLE) following infection with COVID-19.
Giovanna S. Manzano (Brunetto)+4 more
semanticscholar +1 more source
Acute Disseminated Encephalomyelitis Presenting as Bilateral Ptosis in a Sri Lankan Child
Introduction. Acute disseminated encephalomyelitis is a rare inflammatory demyelinating disease characterized by acute onset polyfocal neurological deficits associated with encephalopathy.
Ishara Kumarasiri+5 more
doaj +1 more source
COVID-19-associated acute disseminated encephalomyelitis (ADEM)
A 51-year-old woman with COVID-19 infection developed coma and an impaired oculocephalic response to one side. MRI of the brain demonstrated acute multifocal demyelinating lesions, and CSF testing did not identify a direct cerebral infection.
T. Parsons+5 more
semanticscholar +1 more source
Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination
This report describes the clinical context and autopsy findings in the first reported fatal case of acute disseminated encephalomyelitis (ADEM), developed after being vaccinated using the Oxford/AstraZeneca COVID-19 vaccine.
Fiona Permezel+3 more
semanticscholar +1 more source
Acute disseminated encephalomyelitis in a patient vaccinated against SARS‐CoV‐2
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and there are some data that link this event with various vaccinations. We report a young female admitted to the hospital with headache, fever, back pain, nausea, vomiting, and ...
Karolina Kania+3 more
semanticscholar +1 more source
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature
The literature on cases of acute disseminated encephalomyelitis (ADEM) associated with SARS-CoV-2 infection has been rapidly increasing. However, the specific clinical features of ADEM associated with SARS-CoV-2 (SARS-CoV-2-ADEM) have not been previously
Yumin Wang+5 more
semanticscholar +1 more source